Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(9 sites)
United States
Phoenix Children's Hospital, Phoenix, Arizona Arkansas Children's Hospital, Little Rock, Arkansas City of Hope, Duarte, California Stanford University, Stanford, California Cincinnati Children's Hospital, Cincinnati, Ohio